With 25 years of experience across all phases clinical development spanning large pharma, CROs, consulting and software companies, as well as recently managing a leading oncology phase I clinical research unit in Central London, Matt is part of IQVIA Biotech’s Oncology Strategy team, using this experience to support operational teams and clients in developing robust clinical strategies for novel anti-cancer therapies.